Work

Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium‐glucose co‐transporter‐1 and sodium‐glucose co‐transporter‐2, in patients with chronic kidney disease: A randomized trial

Year: 2021

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.14327

Authors: YanLing He, Alok Pachori, Ping Chen, Shenglin Ma, Anisha E. Mendonza, Ahmed Amer, Thomas C. Marbury, Markus Hinder

Institutions: Novartis (United States), Orlando Clinical Research Center, Novartis Institutes for BioMedical Research

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Institutes for BioMedical Research

OpenAlex ID: W3122205864

FWCI: 0.746

Cites: 33

Cited by: 5

Related to: 10